AKT1 and hepatocellular carcinoma: We further noticed that plumbagin treatment also inhibit the expression of phospho-PI3K and AKT Figure 7, We also demonstrate for the first time the potential of plumbagin to inhibit tumor-induced angiogenesis in HCC patient xenografts implanted in BALB/c mice.